Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Is low-grade serous ovarian cancer part of the tumor spectrum of hereditary breast and ovarian cancer?

Gynecologic oncology - 1 Feb 2011

Vineyard Marisa A, Daniels Molly S, Urbauer Diana L, Deavers Michael T, Sun Charlotte C, Boerwinkle Eric, Bodurka Diane C, Gershenson David M, Crawford Jessica, Lu Karen H

Abstract excerpt

OBJECTIVE: To determine whether women with low-grade serous ovarian cancer (LGSOC) have personal and family histories of breast and ovarian cancer that are less suggestive of Hereditary Breast and Ovarian Cancer (HBOC), as compared to women with high-grade serous ovarian cancer (HGSOC). METHODS: A single institution, case-control retrospective review of medical records was conducted. Personal demographics,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cystadenocarcinoma, Serous

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Genetic Predisposition to Disease

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 21126756
DOI: 10.1016/j.ygyno.2010.10.033

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Is low-grade serous ovarian cancer part of the tumor spectrum of hereditary breast and ovarian cancer?PMID 21126756Read ↗

BRCA mutation in ovarian cancer: testing, implications and treatment considerationsSemantic proximity Read ↗

High-Grade Serous Ovarian Cancer—A Risk Factor Puzzle and Screening FugitiveSemantic proximity Read ↗

Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes.Semantic proximity Read ↗

[Clinical significance and distribution of BRCA genes mutation in sporadic high grade serous ovarian cancer].Semantic proximity Read ↗

The molecular genetics of hereditary and sporadic ovarian cancer: implications for the future.Semantic proximity Read ↗

Borderline Ovarian Tumors Share Familial Risks with Themselves and Invasive Cancers.Semantic proximity Read ↗

Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors.Semantic proximity Read ↗

High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical Factors.Semantic proximity Read ↗

Pathogenesis and heterogeneity of ovarian cancerSemantic proximity Read ↗

The genomic landscape of low-grade serous ovarian/peritoneal carcinoma and its impact on clinical outcomes.Semantic proximity Read ↗

Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer.Semantic proximity Read ↗

Role of common genetic variants in ovarian cancer susceptibility and outcome: progress to date from the Ovarian Cancer Association Consortium (OCAC).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.